Breaking the relentless course of Hallopeau's acrodermatitis by dapsone

European Journal of Dermatology

Volumn 9, Issue 2, 1999, Pages 126-128

  Nikkels, Arjen F ^a,b   Nikkels Tassoudji, Nazli ^b   Piérard, Gérald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b St Josef Hospital   (Belgium)

Author keywords

Acrodermatitis continua; Hallopeau; Neutrophils; Psoriasis; Pustules; Sulfone; Therapy

Indexed keywords

BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; CHLORMETHINE; CLOBETASOL PROPIONATE; CLOBETASONE BUTYRATE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; DAPSONE; DITHRANOL; EMOLLIENT AGENT; ETRETIN; ETRETINATE; FLUOROURACIL; FLUOXETINE; LORMETAZEPAM; METHOTREXATE; MINOCYCLINE; NIFEDIPINE; TAR; TRIAMCINOLONE;

ACRODERMATITIS; AGED; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; HUMAN; HYPERTENSION; INTRALESIONAL DRUG ADMINISTRATION; LUNG DISEASE; MALE; PUSTULE; PUVA; SKIN MANIFESTATION; TOPICAL DRUG ADMINISTRATION;

ACRODERMATITIS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DAPSONE; HUMANS; MALE;

EID: 0032901055     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hallopeau MH. Sur une asphyxie locale des extrémités avec polydactilite suppurative chronique et poussées éphémères de dermatite pustuleuse disséminée et symétrique. Bull Soc Fr Derm Syph 1890; 1: 39-45.
2. White MI, Main RA. The treatment of Hallopeau's acrodermatitis. Arch Dermatol 1979; 115: 235-6.
3. Coleman MD. Dapsone: modes of action, toxicity and possible strategies for increasing patient tolerance. Br J Dermatol 1993; 129: 507-13.
4. Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. Dermatology. Pustular diseases (Chapter 16). Berlin: Springer Verlag, 1991: 502-10.
5. Combemale P, Prost C. Disulone. In: Thérapeutique dermatologique. Dubertret L, ed. Paris: Flammarion Médecine-Sciences, 1991: 756-67.
6. Piraccini BM, Fanti PA, Morrelli R, Tosti A. Hallopeau's acrodermatitis continua of the nail apparatus: a clinical and pathological study of 20 patients. Acta Dermatol Venereol 1994; 74: 65-7.
7. Wilkinson DS. Pustular dermatoses. Br J Dermatol 1969; 81: 38-45.
8. Pearson LH, Allen BS, Smith JG. Acrodermatitis continua of Hallopeau: treatment with etretinate and review of relapsing pustular eruptions of the hands and feet. J Am Acad Dermatol 1984; 11: 755-62.
9. Konrad K. Acrodermatitis continua suppurativa Hallopeau: Behandlung mit Methotrexate. Hautarzt 1970; 21: 119-23.
10. Van Dooren-Greebe RJ, van de Kerkhof PCM, Chang A, Happle R. Acitretin monotherapy in acrodermatitis continua Hallopeau. Acta Derm Venereol 1989; 69: 344-6.
11. Arnold HL. Treatment of Hallopeau's acrodermatitis with triamcinolone acetonide. Arch Dermatol 1978; 114: 963.
12. Zachariae H, Thestrup-Pedersen K. Cyclosporin A in acrodermatitis continua. Dermatologica 1987; 175: 29-32.
13. Notowicz A, Stolz E, Heuvel NVD. Treatment of Hallopeau's acrodermatitis with topical mechlorethamine. Arch Dermatol 1978; 114: 123.
14. Tsuji T, Nishimura M. Topically administered fluorouracil in acrodermatitis continua of Hallopeau. Arch Dermatol 1991; 127: 27-8.
15. Emtestam L, Wedén U. Successful treatment for acrodermatitis continua of Hallopeau using topical calcipotriol. Br J Dermatol 1996; 135: 644-66.
16. Mozzanica N, Cattaneo A, The clinical effect of topical calcipotriol in acrodermatitis continua of Hallopeau. Br J Dermatol 1998; 138: 556.
17. Nguyen VT, Kadunce DP, Hendrix JD, Gammon WR, Zone JJ. Inhibition of neutrophil adherence to antibody by dapsone: a possible therapeutic mechanism of dapsone in the treatment of IgA dermatoses. J Invest Dermatol 1993; 100: 349-55.
18. Booth SA, Moody CE, Dahl MV, Herron MJ, Nelson RD. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol 1992; 98: 135-40.